SGMT

NASD Sagimet Biosciences Inc. Class A
Oct 9, 2026 · 9:24 AM ET LAST TRADE Market Closed

$8.89 ↓ -0.03 (-0.34%) Trading Down from the previous close of $8.92

YTD change
+50.17%
vs 20-day SMA
-10.59%
vs 200-day SMA
+22.98%

Price ranges

Previous day
$8.63 $8.94
open $8.82 close $8.92
+$0.10 (+1.13%)
Today
$0.00 $0.00
$8.89
Past week
$8.40 $9.38
from $9.37 now $8.89
-$0.48 (-5.12%)
Past month
$8.40 $11.40
from $11.06 now $8.89
-$2.17 (-19.62%)
This year
$4.50 $11.45
from $5.92 now $8.89
+$2.97 (+50.17%)

Price & Performance

+3.28 (+58.16%) / 6M

$4.83$7.10$9.37$11.64Apr 9Jul 10Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 57.1% away from all-time highs of $20.71
  • SGMT is up 50% since the beginning of the year
  • SGMT is up 3% over the past 12 months
  • SGMT is down 20% over the past 1 month
  • 16% of all SGMT investors are betting against SGMT

SGMT reads neutral: price sits above one of the two key moving averages, the 12-month move is +3.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.26
Earnings momentum -0.2% Quarterly EPS growth
Quarterly change -0.2%

Valuation

P/E ratio N/A
Enterprise value $235.6M
Beta 3.23

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$240.1M
Debt$1.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $654.8M

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,169.60 -1.61%
JNJ Johnson & Johnson $256.48 -0.76%
ABBV AbbVie, Inc. $272.42 +0.39%
MRK Merck & Co., Inc. $142.38 -0.29%
RHHBY Roche Holding Ltd Sponsored ADR $53.37 -1.29%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.